Demecarium bromide is a potent, long-acting cholinesterase inhibitor belonging to the quaternary ammonium class, primarily utilized as a parasympathomimetic agent to treat glaucoma by reducing intraocular… Read more
Demecarium bromide is a potent, long-acting cholinesterase inhibitor belonging to the quaternary ammonium class, primarily utilized as a parasympathomimetic agent to treat glaucoma by reducing intraocular pressure through miosis and improved aqueous humor outflow. Laboratories rely on high-quality reference standards for this compound to support critical analytical workflows. The available related compounds, including identified impurities, metabolites, and stable isotope-labelled standards, are essential for rigorous impurity profiling and method validation. By utilizing these materials, pharmaceutical analysts can ensure accuracy in potency assays and the detection of degradation products, facilitating robust quality control of pharmaceutical formulations throughout the development and manufacturing lifecycle.